A PROSPECTIVE STUDY ON IMPACT OF PATIENT COUNSELLING ON QUALITY OF LIFE AND MEDICATION ADHERENCE IN EPILEPTIC PATIENTS

Authors

  • Ayswarya P
  • Sathesh Kumar s Professor and HOD,Department of Pharmacuetics,School of Pharmaceutical Sciences,Vels Institute of Science Technology and Advanced Studies (VISTAS),Vels University,Pallavaram, Chennai-600117.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i1.13106

Abstract

Objective: To study the impact of patient counseling on medication adherence and quality of life (QOL) in epileptic patients and to assess the factors affecting medication adherence.

Methods: This study is a prospective observational study involving 100 patients with an age limit of 8-60 years and those taking Antiepileptic drugs for at least 3 months. The study population received patient counseling during their first visit. The impact of patient counseling on QOL and medication adherence was assessed using self-reported questionnaire QOLIE-31 and MMAS-8 between the first visit and the second visit. Statistical analysis (Paired t-test and Paired Chi-square test) was performed to analyze the impact of patient counseling on QOL and medication adherence in epileptic patients.

Results: A total of 100 patients were included in the study. After providing patient counseling, it was observed that there was a statistically significant (p<0.05) improvement in all domains of QOLIE-31 and MMAS-8 scores. Before counseling, mean overall T-score of QOLIE-31 was 44.08±2.07which was changed to 49.14±1.27 after patient counseling with a mean change of 5.06 in overall T-score. In the case of medication adherence, before counseling 77% subjects were nonadherent to therapy, after counseling it was reduced to 41%. The common reasons for medication adherence were forgetfulness, unawareness, therapy related, and economics related. Out of which forgetfulness along with unawareness was the major one.

Conclusion: The study described that patient counseling plays a major role in improving QOL and medication adherence.

Keywords: QOLIE-31, MMAS-8, Epilepsy, Antiepileptic drugs, Patient counseling.

 

Downloads

Download data is not yet available.

Author Biography

Sathesh Kumar s, Professor and HOD,Department of Pharmacuetics,School of Pharmaceutical Sciences,Vels Institute of Science Technology and Advanced Studies (VISTAS),Vels University,Pallavaram, Chennai-600117.

Professor and HOD,
Department of Pharmacuetics,
School of Pharmaceutical Sciences,
Vels Institute of Science Technology and Advanced Studies (VISTAS),
Vels University,
Pallavaram, Chennai-600117.

References

Haut SR, Velísková J, Moshé SL. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol 2004;3(10):608-17.

About Epilepsy. US Department of Veterans Affairs; 2015. Available from: http://www.VA/healthcare/epilepsy centers of excellence/about epilepsy. [Last cited on 2015 Jun 3].

Schachter CS. Epilepsy Foundation. Available from: http://www. epilepsy. com/learn/types-seizures.

Gabr WM, Shams ME. Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J 2015;23(1):33-40.

Martins HH, Alonso BN, Guilho FF, Guaranha BS, Yacubian TM. Adherence to treatment in patients with juvenile myoclonic epilepsy: Correlation with QOL and ADR of medication. J Epilepsy Clin Neurophysiol 2009;15(4):192-6.

Johnbull OS, Farounbi B, Adeleye AO, Ogunrin O, Uche AP. Evaluation of factors influencing medication adherence in Kaduna state Nigeria. Neurosci Med 2011;2(4):299-305.

Study: What Affects Quality of Life in Patients with Epilepsy? Available from: https://www.freshsciencenews.wordpress.com/2015/06/12/ study-what-affects-quality-of-life-in-patients-with-epilepsy/. [Last updated on 2014 Jun ???].

Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 2002;20(15):1039-59.

Ahmad N, Othaman NI, Islahudin F. Medication adherence and quality of life in epilepsy patients. Int J Pharm Pharm Sci2013;5(2):401-4.

McCagh J, Fisk JE, Baker GA. Epilepsy, psychosocial and cognitive functioning. Epilepsy Res 2009;86(1):1-14.

Kerr MP, The impact of epilepsy on patients’lives. Acta Neurol Scand Suppl.2012;(194):1-9. DOI: 10.1111/ane.12014.

Hovinga CA, Asato MR, Manjunath R, Wheless JW, Phelps SJ, Sheth RD, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians. Epilepsy Behav 2008;13(2):316-22.

Ashjazadeh N, Yadollahikhales G, Ayoobzadehshirazi A, Sadraii N, Hadi N. Comparison of the health-related quality of life between epileptic patients with partial and generalized seizure. Iran J Neurol 2014;13(2):94-100.

Garnett WR. Antiepileptic drug treatment: Outcomes and adherence. Pharmacotherapy 2000;20(8):191S-9.

Nabukenya AM, Matovu JK, Wabwire-Mangen F, Wanyenze RK, Makumbi F. Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: A cross- sectional study. Health Qual Life Outcomes 2014;12:49.

Gabr WM and Shams MEE, Adherence to medication among outpatient adolescents with epilepsy, Saudi

Pharmaceutical Journal, 2015;23 (1): 33-40.

Brusturean BE, Coada CA, Buzoianu AD, Dumbrava LP. Assessment of quality of life in patients with epilepsy. Int J Bioflux Soc 2013;5(3):82-7.

Sweileh WM, Ihbesheh MS, Jarar IS, Taha AS, Sawalha AF, Zyoud SH, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 2011;21(3):301-5.

Dourado MV, Alonso NB, Martins HH, Oliveira AR, Vancini RL, de Lima C, et al. Quality of life and self - Perception impact of epilepsy in three different epilepsy types. J Epilepsy Clin Neurophysiol 2007;13(4):191-6.

Shanmukhi S, SitaJayalakshmi S, Anand. B. Factors associated with quality of life in adult epilepsy patients: A hospital based study from South India, Res Neurol Int J 2015;2015:Article ID: 766328, DOI: 10.5171/2015.766328.

Published

01-01-2017

How to Cite

P, A., and S. K. s. “A PROSPECTIVE STUDY ON IMPACT OF PATIENT COUNSELLING ON QUALITY OF LIFE AND MEDICATION ADHERENCE IN EPILEPTIC PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 1, Jan. 2017, pp. 67-71, doi:10.22159/ajpcr.2017.v10i1.13106.

Issue

Section

Original Article(s)